Sarepta Therapeutics | SRPT - EPS Earnings Per Share


Sarepta Therapeutics reported $3.16 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.23 -0.13 Nov/04
FY2026Q2 Jun/2026 0.21 2.02 Aug/05
FY2026Q1 Mar/2026 3.16 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Moderna USD -1.97 1.43 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.09 0.21 Jun/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026